Dar Delivers Detailed Design and Sustainability Strategy for New Aramco Stadium in Al Khobar
Aramco, one of the world’s leading integrated energy and chemicals companies, in collaboration with leading real estate company ROSHN has announced the commencement of construction on Aramco Stadium, Al Khobar’s new 47,000-spectator stadium which is planned to meet international standards for the world’s premier football competitions, such as the 2027 AFC Asian Cup, the FIFA World Cup 2034 — which the Kingdom is bidding to host — as well as other showpiece entertainment events.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240902666406/en/
New Aramco Stadium in Al Khobar (Photo AETOSWire)
Dar Al-Handasah Consultants (Shair and Partners) — Dar — was responsible for developing and delivering the detailed design of this iconic new stadium, actualizing the signature architect’s vision of a stunning new structure inspired by the natural environment. Dar also delivered the detailed design of the mixed-use masterplan facilities and infrastructure.
Dar’s sister Sidara company Maffeis Engineering – one of the world’s most specialized structural engineering consultancies – delivered the detailed design of the stunning and structurally unique roof and façade system.
Dar also crafted the sustainability strategy for the stadium, targeting LEED and Mostadam certifications and setting exceptional standards for sustainable stadiums in hot climates, while aligning with Saudi Vision 2030, the Saudi Green Initiative and local and international regulations. The strategy includes measures for implementing passive and active energy efficiency incorporating demand response technologies, reducing water use, diverting operational waste away from landfills, and specifying eco-friendly, local, and recycled products.
About Dar and Sidara
Dar is the founder of Sidara, a global collective of over 20,000 planners, designers, engineers, and consultants, who have come together, in 300 offices across all geographies, on a shared mission: to advocate for the world as we would for our own home. Beyond Dar, Sidara’s firms include Perkins&Will, TYLin, Maffeis, Currie&Brown, and Penspen.
Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20240902666406/en/
Contacts
Dar
Marketing & Communications
Haya Yahya
MC@dar.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Reveal Officially Releases its Logikcull Platform Throughout Europe17.9.2024 11:00:00 CEST | Press release
Reveal, the global provider of the leading AI-powered eDiscovery and investigations suite of technologies,announced today the launch of its Logikcull platform in Europe. This strategic expansion introduces customers to Logikcull’s lightweight, self-service option, while simultaneously broadening access to its enterprise-grade, feature-rich platform, driven by the most powerful AI engine in the industry. Reveal’s dual-platform approach uniquely positions the company to offer customers across Europe and beyond more choice in how to solve their diverse set of legal challenges. “The introduction of Logikcull by Reveal to the European market highlights our continued commitment to bridging the justice gap by automating the practice of law for all - not just a privileged few. In less than a year since our acquisition of Logikcull, I’m proud that our strategic investment in Logikcull has taken the platform from a national success story to now a global one,” said Wendell Jisa, Founder & CEO of
LabVantage Solutions Partners with Henkel on New Integrated Platform to Drive R&D Digital Transformation17.9.2024 11:00:00 CEST | Press release
LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services, including purpose-built LIMS platforms enabling rapid deployment at reduced costs, today announced a collaboration with Henkel AG & Co. KGaA ("Henkel"), to integrate LabVantage LIMS and SAP Product Lifecycle Management (PLM) solutions into Henkel’s core R&D 4.0 platform for its consumer businesses. This strategic decision for LabVantage Solutions was driven by Henkel’s commitment to advancing innovation, sustainability, and digital transformation within its organization. Henkel is a prominent leader in the consumer goods industry, excelling across both its industrial and consumer divisions, where it holds top market positions. The company’s new integrated platform will leverage LabVantage LIMS and SAP PLM for end-to-end business integration, data sharing, and reporting. Enhanced with automation, data mining, and knowledge-sharing technologies, it aims to drive breakthroughs in product dev
NRF and Comexposium Expand Retail’s Big Show to Europe17.9.2024 11:00:00 CEST | Press release
The National Retail Federation and Paris-based event organizer Comexposium today announced that the Paris Retail Week annual conference and exhibition is being rebranded beginning in 2025. The inaugural NRF 2025: Retail’s Big Show Europe will be held Sept. 16 – 18, 2025, at the Paris Porte de Versailles Pavilions 4 & 6. It is expected to draw thousands of retailers and business partners from across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240916040288/en/ “NRF is proud to represent the largest global retail brands in the world, and we are excited to expand our award-winning educational experiences into new markets, complementing the annual Big Show in New York City and Retail’s Big Show Asia Pacific,” NRF President and CEO Matthew Shay said. “Every single day, successful retailers are exploring new tools, new approaches and new innovations to remain relevant to loyal shoppers and new customers alike. For nearly
Gcore Introduces AI-Driven Web Application and API Protection at the Edge17.9.2024 10:00:00 CEST | Press release
Gcore, the global edge AI, cloud, network, and security solutions provider, today announced the launch of Gcore WAAP, its end-to-end web application and API protection solution. Leveraging advanced AI capabilities, Gcore WAAP integrates four powerful products in one solution: web application firewall (WAF), application-layer DDoS protection, bot management, and API security, all managed through an intuitive user interface. This comprehensive, multi-layered security solution protects digital assets across a wide range of verticals, including retail, financial services, healthcare, public sector, media and entertainment, and technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240917971916/en/ Gcore WAAP delivers comprehensive web application and API protection against a broad range of advanced threats (Graphic: Business Wire) Gcore WAAP was developed following the company’s acquisition of the StackPath WAAP solution ear
Enzian Pharmaceutics Develops a Novel Dosage Form for Enhanced Efficacy and Reduced Side Effects of Cancer Therapies17.9.2024 09:21:00 CEST | Press release
At present, the prevalent oral solid dosage forms, the capsules and tablets, are loose or lightly compacted mixtures of drug and excipient particles. Upon ingestion, they rapidly disintegrate into their constituents in the stomach. The small drug particles then are swept out of the stomach and pass through the intestine. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240917927016/en/ Dr. Aron Blaesi, inventor of expandable, gastroretentive fibrous dosage forms presenting dosage forms before and after expansion due to water absorption. (Photo: Business Wire) Many kinds of cancer drug, however, are absorbed only in the acidic upper part of the gastrointestinal tract. Because the gastric residence time of the drug particles (~2-3 hours) is much shorter than the convenient dosing interval (~12-24 hours), upon repeated dosing of such drugs the drug concentration in blood fluctuates greatly. This is therapeutically not optimal: Th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom